Biosurgery Market Growth Accelerated By Rising Adoption Rate
Biosurgery refers to surgical procedures that rely on natural or synthetic biomaterials originating from living sources. Biosurgery products such as hemostat and sealants help control bleeding during surgeries and repair damaged or ruptured tissues. These products play a crucial role in reducing blood loss and speeding up recovery for patients undergoing complex surgeries.
The global Biosurgery Market
is estimated to be valued at US$
18282.35 Bn in 2024 and is expected
to exhibit a CAGR of 9.5% over the forecast period 2024 to 2031, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising adoption rate of biosurgery products across various medical
procedures has been a key trend driving the market growth. These products help
control internal bleeding by initiating the body's own self-repair mechanisms during
surgery and reduce postoperative complications and hospital stays. Moreover,
growing preference for minimally invasive surgical procedures has further
boosted the demand for biosurgery products that assist in quicker healing.
Technological advancements leading to development of new generation adhesion
prevention solutions, hemostats and sealants have expanded the applications of
biosurgery products in recent years. This has accelerated market expansion over
the forecast period.
Segment Analysis
The global biosurgery market is dominated by the tissue management sub-segment.
This sub-segment deals with controlling blood loss and repairing tissues. It
held around 40% market share in 2021 due to rising prevalence of cardiovascular
diseases, orthopedic disorders, and injuries that require advanced surgical
procedures. The demand for effective hemostats and tissue sealants is high to
manage blood loss and repair tissues during surgeries.
Key Takeaways
The global Biosurgery
Market Size is expected to witness high growth in the coming years.
Regional analysis: The Asia
Pacific biosurgery market is projected to grow at the fastest pace during the
forecast period. This is attributed to growing medical tourism industry, rising
healthcare spending, increasing incidence of lifestyle diseases, expanding
private healthcare sector, and improving regulatory guidelines in the region.
China, India, and Japan are emerging as prominent biosurgery markets in Asia
Pacific.
Key players operating in the biosurgery market are Akzo Nobel N.V., PPG
Industries, Inc., Sherwin-Williams Company, and BASF SE. They are focusing on
new product launches, expansions, mergers and acquisitions to strengthen their
market presence. For instance, in 2021, Akzo Nobel N.V. acquired a leading
protective coatings manufacturer BASF’s industrial coatings business to expand
its industrial coatings portfolio.
Explore more
related article on this topic: https://www.newsanalyticspro.com/biosurgery-is-driving-advancements-in-tissue-regeneration-and-reconstruction/

Comments
Post a Comment